Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1602 of 6351
-
Could a new formula forecast lung trouble after surgery?
Knowledge-focused CompletedThe goal of this prospective observational study is to determine whether novel oxygenation and oxygen saturation indices that incorporate total or dynamic mechanical power can predict postoperative pulmonary complications (PPCs) in adults undergoing major abdominal surgery. The m…
Sponsor: Hadeer Yasser Abd El-aliem • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
AI-Designed vaccine takes on deadly brain cancer in first human trial
Disease control Recruiting nowGliomas are a heterogeneous group of tumors arising from glial cells in the central nervous system and are associated with poor prognosis and significant morbidity. The most aggressive form, glioblastoma multiforme (GBM), remains particularly challenging to treat, often exhibitin…
Early phase 1 • Sponsor: Biogenea Pharmaceuticals Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New registry study tests antibody drugs for rare nerve disease
Disease control Recruiting nowThe primary objective of this registry study is to evaluate the therapeutic efficacy and safety profiles of distinct monoclonal antibody-based therapies for aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorders within the Chinese population under real-…
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:35 UTC
-
Could a simple pill help save sight in wet AMD?
Disease control Recruiting nowThis study will evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of Oral HX9428 tablets in patients with wet age-related macular degeneration(wAMD)
Phase 1/2 • Sponsor: Fujian Haixi Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug aims to reverse fatty liver damage in MASH patients
Disease control Recruiting nowThis is a multicenter, randomized, double-blind, placebo-controlled Phase 2 clinical study evaluating the efficacy and safety of IBI362 in MASH subjects. Subjects will be randomly assigned to IBI362 low-dose, high-dose and placebo groups. The entire trial cycle includes a 8-week …
Phase 2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
AI vs. heart attacks: could a computer triage chest pain faster?
Diagnosis Recruiting nowThis study is to see whether the AI ECG assisted protocol is as safe and efficacious as conventional protocol in early triage of suspected myocardial infarction.
Sponsor: CHA University • Aim: Diagnosis
Last updated Jul 30, 2026 00:00 UTC
-
New strategy aims to boost TB detection and treatment in ethiopia
Disease control OngoingEffective tuberculosis treatment outcome relies on adherence. However, many TB patients struggle to adequately adhere to their prescribed regimen due to various social, economic, personal, and healthcare system barriers. However, previous interventions did not adequately consider…
Sponsor: Arba Minch University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Stents or pills for 80+ heart patients? new study seeks answers
Disease control OngoingThe study compares an interventional strategy (PCI) with optimal medical therapy (OMT) in ultra-octogenarians with chronic total occlusions (CTO). Results suggest that successful PCI leads to significant improvements in symptoms and quality of life compared to OMT alone. While i…
Sponsor: San Luigi Gonzaga Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Shock therapy vs. ketamine: which works better for severe depression?
Symptom relief CompletedThis study aimed to compare the efficacy, safety, and tolerability of electroconvulsive therapy (ECT) versus intravenous (IV) ketamine in adults with treatment-resistant major depressive disorder (TRD).
Sponsor: Tanta University • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Can exercise and music beat dementia? a new study targets At-Risk veterans
Disease control Recruiting nowThis study will begin to evaluate personalized preventative dementia treatments for Veterans at risk for developing dementia. The investigators will target Veterans with Motoric Cognitive Risk syndrome (MCR), which is characterized by slow gait speed and cognitive concerns (e.g.,…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Which pain block works best for kids after hernia surgery?
Symptom relief CompletedThis randomized controlled trial aims to compare the analgesic efficacy of local wound infiltration with Ropivacaine versus Caudal Block with Ropivacaine in pediatric patients undergoing surgery for inguinal hernia
Sponsor: Fatima Memorial Hospital • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
New hope for IVF patients: drug may prevent dangerous ovarian overreaction
Disease control Recruiting nowOvarian hyperstimulation syndrome (OHSS) is a serious iatrogenic complication of controlled ovarian stimulation of gonadotrophin-Stimulated ovarian cycles. It is theorized to manifest systemically as a result of vasoactive mediators like vascular endothelium growth factor (VEGF) …
Phase 2 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New chemo cocktail targets rare small bowel tumors
Disease control Recruiting nowThe study regimen will be administered on an outpatient basis and all medications are administered intravenously (IV). Subjects will receive treatment on Day 1 and Day 15 of each 28-day cycle consisting of the following: nanoliposomal irinotecan at 50 mg/m2, followed by oxaliplat…
Phase 2 • Sponsor: Tiago Biachi de Castria • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New shot aims to ease neck pain for months longer
Symptom relief Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of the study drug, Corabotase (also known as IPN10200), and to assess how well it works when compared with placebo in treating Cervical Dystonia (CD) in adults. CD can cause a series of abnormalities and symptoms i…
Phase 2 • Sponsor: Ipsen • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
New rapid test could slash ER wait times for chest pain patients
Diagnosis Recruiting nowThe goal of this study is to evaluate whether a POC-guided testing strategy to exclude non-ST elevation myocardial infarction (NSTEMI) in acute chest pain patients presenting at the emergency department (ED) can result in a shorter length of stay compared to the routine central l…
Sponsor: KU Leuven • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
New obesity drug GV101 shows promise in Mid-Stage trial
Disease control CompletedThe purpose of this trial is to evaluate the efficacy and safety of GV101 for weight loss over a range of doses in participants with obesity. The primary efficacy endpoint is the mean percent change in body weight from baseline at Week 16 in each treated group as compared with pl…
Phase 2 • Sponsor: Graviton Bioscience Corporation • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New hope for duchenne: experimental drug targets genetic flaw
Disease control Recruiting nowThis is a study of the investigational medicine ENTR-601-44 in participants who have Duchenne muscular dystrophy (DMD), a rare genetic condition. The researchers want to: Test how safe ENTR-601-44 is, learn about any side effects, and look at the potential positive effects of EN…
Phase 1/2 • Sponsor: Entrada Therapeutics, Inc. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New hope for rare lung infection: weekly drug shows promise in early trial
Disease control OngoingThe goal of this clinical trial is to to evaluate the drug rezafungin in the treatment of Chronic Pulmonary Aspergillosis (CPA) in male and female patients aged 18 years and over with limited treatment options. The study aims to answer whether 6 months of rezafungin treatment is…
Phase 2 • Sponsor: Mundipharma Research Limited • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could a liver drug help kids and adults with rare metabolic disorder?
Disease control Recruiting nowThis is a medical research study to test a medication in patients 4 years of age and older with a disease called medium-chain acyl-CoA dehydrogenase deficiency (MCADD) caused by the common ACADM c.985 A\>G (K304E) mutation. The medication is sodium phenylbutyrate (ACER-001), whic…
Phase 2 • Sponsor: Jerry Vockley, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Can a tropical tea shrink blood cancers?
Disease control Recruiting nowPurpose/Specific Aims The study will determine if there is a reduction in malignant cell burden when patients with relapsed and/or refractory acute myeloid leukemia (AML) or multiple myeloma (MM) consume tea made from the dried leaves of Annona muricata (Soursop). The study goa…
Early phase 1 • Sponsor: Roger Strair • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC